S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 20,350
-850 (-4.01%)
At close: Oct 22, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 252.04 billion as of October 22, 2026. It is the 20,766th most valuable company in the world and the 691st biggest in South Korea. Its market cap has decreased by 9.18% in one year.
Market Cap
252.04B
Enterprise Value
232.29B
Revenue
16.49B
Global Rank
Country Rank
#691 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 252.04B, an increase of 22.02%. That is a compound annual growth rate of 5.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 252.04B | -44.42% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 369.86B |
| Curocell | 366.21B |
| AprilBio | 363.12B |
| Inventage Lab | 334.02B |
| HansBiomed | 270.97B |
| IntoCell | 254.77B |
| Genome & Company | 220.44B |
| IMBiologics | 213.20B |